Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
CU-CPT9a is a drug which acts as a potent and selective antagonist of Toll-like receptor 8 (TLR8), with an IC50 of 0.5nM. Activation of toll-like receptors triggers release of cytokines and other signalling factors, leading to inflammation. This is an essential part of the immune system's response to infection, but chronic activation of TLR signalling is…
The analysis highlights Art and Overview as prominent areas in the source structure around CU-CPT9a.
Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.
Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Explore different angles and find fresh ideas to shape your next piece of content.
Search suggestions related to this topic. Open a question to research it further; suggestions are not verified answers.
Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.
You can skip this section if you’re here for content ideas and keyword inspiration.
The extracted context around CU-CPT9a shows recurring relationship patterns in the source. For example, CU-CPT9a → Interactive image Another extracted example is CU-CPT9a → 2165340-32-7. Use these groups to spot repeated connection types before inspecting the individual relationships.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
toll-like tlr8 activation signalling autoimmune disorders cytokines inflammation immunosuppressant drug acts potent selective antagonist receptor ic50 5nm receptors triggers release
TTTA extracted 8 structured relationships around CU-CPT9a. Examples in this analysis include CU-CPT9a → 3D model (JSmol) → Interactive image and CU-CPT9a → CAS Number → 2165340-32-7. The table shows each extracted connection, where it came from and its confidence.
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| CU-CPT9a | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| CU-CPT9a | CAS Number | 2165340-32-7 | 1.00 | infobox |
| CU-CPT9a | ChemSpider | 65323639 | 1.00 | infobox |
| CU-CPT9a | Formula | C17H15NO2 | 1.00 | infobox |
| CU-CPT9a | Molar mass | 265.312 g·mol−1 | 1.00 | infobox |
| CU-CPT9a | PubChem CID | 135567383 | 1.00 | infobox |
| CU-CPT9a | UNII | 6BNV86VAQ8 | 1.00 | infobox |
| CU-CPT9a | is a | drug which acts as a potent and selective antagonist of Toll-like receptor 8 | 0.90 | text |
The concept neighborhoods around CU-CPT9a bring nearby vocabulary together. In this analysis, examples include Tlr8, 5nm and Acts. Use the clusters to find adjacent concepts and terminology that may deserve separate research.
Bridges highlight paths between different parts of the CU-CPT9a map and can reveal research angles that are easy to miss in a flat list.
TTTA analyzes the structure around CU-CPT9a to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as Art & Overview, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.
Source: Wikipedia — CU-CPT9a · EN edition · Analysis: TopicsToTalkAbout